MYRIAD GENETICS INC.

Myriad Genetics to Release Fourth-Quarter 2021 Financial Results on February 24, 2022

16 Feb 2022 07:05:00 By Nasdaq GlobeNewswire

Myriad Genetics to Present at Two Upcoming Healthcare Conferences

14 Feb 2022 07:05:00 By Nasdaq GlobeNewswire

Myriad Genetics CEO Paul Diaz to Speak at 40th Annual J.P. Morgan Health Care Conference

05 Jan 2022 07:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Chief Scientific Officer Jerry Lanchbury Retires after 19 Years of Service

04 Jan 2022 16:47:10 By Nasdaq GlobeNewswire

New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey

15 Dec 2021 10:47:48 By Nasdaq GlobeNewswire

The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults

15 Dec 2021 07:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Promotes Nicole Lambert to Chief Operating Officer

14 Dec 2021 16:05:00 By Nasdaq GlobeNewswire

The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults

23 Nov 2021 07:05:00 By Nasdaq GlobeNewswire

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment

22 Nov 2021 07:05:00 By Nasdaq GlobeNewswire

Myriad Genetics Reports Third Quarter 2021 Results, Continues Strong Execution of Strategic Growth & Transformation Plans

02 Nov 2021 08:30:02 By Nasdaq GlobeNewswire